EXEL
Exelixis Inc
58.00$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.5% | 44.8% | 46.1% | 53.3% | 52.4% | 49.8% | 49.2% | 44.1% | 49.7% | 50.7% | 46.6% | 50.1% | |
| 13.3% | 8.9% | 9.3% | 7.2% | 8.7% | 7.4% | 6.5% | 6.1% | 13.3% | 17.0% | 8.7% | 11.3% | |
| 37.1% | 33.8% | 34.4% | 36.1% | 40.2% | 37.7% | 36.3% | 29.5% | 35.0% | 37.2% | 30.0% | 33.7% | |
| 8.3% | 8.1% | 8.6% | 14.3% | 9.1% | 9.0% | 9.9% | 10.9% | 11.0% | 10.1% | 12.7% | 13.4% | |
| 0.8% | 0.6% | 0.8% | 0.7% | 0.7% | 0.8% | 0.9% | 0.9% | 1.0% | 0.8% | 1.0% | 1.2% | |
| 12.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 2.1% | 2.2% | 2.3% | 2.3% | 2.2% | 2.2% | 2.2% | 2.4% | 2.3% | 2.2% | 2.5% | 2.6% | |
| 21.1% | 23.1% | 24.1% | 23.6% | 23.1% | 23.9% | 24.9% | 24.1% | 23.5% | 24.0% | 25.4% | 26.1% | |
| 12.7% | 13.4% | 13.3% | 12.5% | 13.3% | 13.7% | 14.1% | 12.6% | 13.2% | 14.3% | 14.3% | 14.5% | |
| 0.2% | 0.9% | 0.1% | – | -0.1% | 0.8% | – | – | – | – | – | – | |
| 0.9% | 1.1% | 0.9% | 1.0% | 2.0% | 1.3% | 1.5% | 1.0% | 0.9% | 1.0% | 0.9% | 1.6% | |
| 78.9% | 76.9% | 75.9% | 76.4% | 76.9% | 76.1% | 75.1% | 75.9% | 76.5% | 76.0% | 74.6% | 73.9% | |
| -4.2% | -5.9% | -9.2% | -7.2% | -3.1% | -3.3% | -5.8% | -8.2% | -3.8% | -2.7% | -8.3% | -10.5% | |
| 10.7% | 10.6% | 10.9% | 10.6% | 9.8% | 9.6% | 10.2% | 10.6% | 9.9% | 9.9% | 10.3% | 10.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.